Volume 24, Issue 2 (March 2022) 24, 225–225; 10.4103/aja202155
Dexamethasone use in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate: this “cort” is not out of order!
Charles Van Praet1, Valérie Fonteyne2, Nicolaas Lumen1
1 Department of Urology, Ghent University Hospital, Ghent 9000, Belgium 2 Department of Radiation Oncology, Ghent University Hospital, Ghent 9000, Belgium
Correspondence: Dr. C Van Praet (charles.vanpraet@uzgent.be)
Date of Submission 18-Jun-2021 Date of Acceptance 28-Jun-2021 Date of Web Publication 27-Aug-2021
|